ICU Medical Inc. (ICUI)

254.45
2.30 0.93
NASDAQ : Health Technology
Prev Close 252.10
Open 253.35
Day Low/High 251.95 / 257.30
52 Wk Low/High 149.60 / 265.27
Volume 44.36K
Avg Volume 127.70K
Exchange NASDAQ
Shares Outstanding 20.29M
Market Cap 5.09B
EPS 3.50
P/E Ratio 76.32
Div & Yield N.A. (N.A)

Latest News

Six Off the Beaten Path Healthcare Stock Gems

Six Off the Beaten Path Healthcare Stock Gems

These lesser-known diagnostic and life sciences firms are involved in areas from genetic tools to telemedicine.

ICU Medical, Inc. Announces Third Quarter 2017 Results

ICU Medical, Inc. Announces Third Quarter 2017 Results

Company Updates FY 2017 Guidance and Provides Initial FY 2018 EBITDA and Adjusted EPS Guidance

ICU Medical Completes The Acquisition Of Hospira Infusion Systems From Pfizer

The addition of Hospira's IV pumps, solutions, and devices business to ICU Medical's existing portfolio creates a leading pure-play infusion therapy company with focus and global scale

Drugmakers Plan Huge Deals in 2017 -- and Banks Will Collect Big Fees

Drugmakers Plan Huge Deals in 2017 -- and Banks Will Collect Big Fees

Here are the winning banks.

ICU Medical Wins Big Price Cut to Buy Pfizer's Hospira Unit

ICU Medical Wins Big Price Cut to Buy Pfizer's Hospira Unit

ICU Medical will pay $900 million for the infusion therapy unit rather than $1 billion.

These 5 Health Care Stocks Are Breaking Out This Christmas

These 5 Health Care Stocks Are Breaking Out This Christmas

The health care sector has been a miserable performer lately -- but these five health trades are bucking the trend.

Short Interest Increases 55.7% For ICUI

Short Interest Increases 55.7% For ICUI

The most recent short interest data has been released for the 10/31/2016 settlement date, which shows a 296,246 share increase in total short interest for ICU Medical, Inc. , to 828,440, an increase of 55.67% since 10/14/2016.

ICUI Crosses Above Average Analyst Target

ICUI Crosses Above Average Analyst Target

In recent trading, shares of ICU Medical, Inc. have crossed above the average analyst 12-month target price of $142.50, changing hands for $142.80/share.

ICU Medical (ICUI) Stock Closed Higher on $1 Billion Pfizer Deal

ICU Medical (ICUI) Stock Closed Higher on $1 Billion Pfizer Deal

ICU Medical (ICUI) purchased Pfizer's (PFE) infusion therapy business for $1 billion,

Stocks Hold Mixed as Crude Settles Above $50, Wall Street Eyes Jobs Report

Stocks Hold Mixed as Crude Settles Above $50, Wall Street Eyes Jobs Report

Stocks hold mixed on Thursday afternoon as crude oil enjoys another rally and Wall Street looks toward the Friday release of the monthly jobs report.

ICU Medical Deal No Game Changer for Pfizer

The deal will close in the first quarter.

ICU Medical Inc. To Acquire The Hospira Infusion Systems Business from Pfizer Inc. For $1 Billion In Cash And Stock

ICU Medical Inc. To Acquire The Hospira Infusion Systems Business from Pfizer Inc. For $1 Billion In Cash And Stock

The addition of Hospira's IV pumps, solutions, and devices business to ICU Medical's existing portfolio will create a leading pure-play infusion therapy company

TheStreet Quant Rating: A (Buy)